These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11044777)

  • 1. Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia.
    Tarkowski E; Ringqvist A; Blennow K; Wallin A; Wennmalm A
    Dement Geriatr Cogn Disord; 2000; 11(6):322-6. PubMed ID: 11044777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal release of nitric oxide and its relation to final brain damage in patients with stroke.
    Tarkowski E; Ringqvist A; Rosengren L; Jensen C; Ekholm S; Wennmalm A
    Cerebrovasc Dis; 2000; 10(3):200-6. PubMed ID: 10773646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cerebrospinal fluid oxidized NO metabolites, nitrite and nitrate, in Alzheimer's disease and vascular dementia of Binswanger type and multiple small infarct type.
    Tohgi H; Abe T; Yamazaki K; Murata T; Isobe C; Ishizaki E
    J Neural Transm (Vienna); 1998; 105(10-12):1283-91. PubMed ID: 9928897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.
    Tarkowski E; Issa R; Sjögren M; Wallin A; Blennow K; Tarkowski A; Kumar P
    Neurobiol Aging; 2002; 23(2):237-43. PubMed ID: 11804709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
    Minta K; Brinkmalm G; Portelius E; Johansson P; Svensson J; Kettunen P; Wallin A; Zetterberg H; Blennow K; Andreasson U
    J Alzheimers Dis; 2021; 79(2):729-741. PubMed ID: 33337373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia.
    Olsson B; Hertze J; Ohlsson M; Nägga K; Höglund K; Basun H; Annas P; Lannfelt L; Andreasen N; Minthon L; Zetterberg H; Blennow K; Hansson O
    J Alzheimers Dis; 2013; 34(3):673-9. PubMed ID: 23254629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia.
    Tarkowski E; Wallin A; Regland B; Blennow K; Tarkowski A
    Acta Neurol Scand; 2001 Mar; 103(3):166-74. PubMed ID: 11240564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia.
    Parnetti L; Reboldi GP; Gallai V
    Neurology; 2000 Feb; 54(3):735-7. PubMed ID: 10680813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease.
    Tarkowski E; Liljeroth AM; Nilsson A ; Minthon L; Blennow K
    Dement Geriatr Cogn Disord; 2001; 12(5):314-7. PubMed ID: 11455132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia.
    Nägga K; Hansson O; van Westen D; Minthon L; Wennström M
    J Alzheimers Dis; 2014; 42(4):1435-41. PubMed ID: 25024336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
    Heilig M; Sjögren M; Blennow K; Ekman R; Wallin A
    Biol Psychiatry; 1995 Aug; 38(4):210-6. PubMed ID: 8547442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of laminins in the cerebrospinal fluid obtained from patients with Alzheimer's disease and vascular dementia using a modified enzyme-linked immunosorbent assay.
    Matsuda K; Tashiro K; Hayashi Y; Monji A; Yoshida I; Mitsuyama Y
    Dement Geriatr Cogn Disord; 2002; 14(3):113-22. PubMed ID: 12218253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics.
    Kim SB; Hill M; Kwak YT; Hampl R; Jo DH; Morfin R
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5199-206. PubMed ID: 14602750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.
    Tarkowski E; Blennow K; Wallin A; Tarkowski A
    J Clin Immunol; 1999 Jul; 19(4):223-30. PubMed ID: 10471976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of memory impairment and perseverative behavior discriminate early Alzheimer's disease from subcortical vascular dementia.
    Traykov L; Baudic S; Raoux N; Latour F; Rieu D; Smagghe A; Rigaud AS
    J Neurol Sci; 2005 Mar; 229-230():75-9. PubMed ID: 15760623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.
    Olsson B; Hertze J; Lautner R; Zetterberg H; Nägga K; Höglund K; Basun H; Annas P; Lannfelt L; Andreasen N; Minthon L; Blennow K; Hansson O
    J Alzheimers Dis; 2013; 33(1):45-53. PubMed ID: 22890100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
    Boban M; Grbić K; Mladinov M; Hof PR; Süssmair C; Ackl N; Stanić G; Bader B; Danek A; Simić G
    Coll Antropol; 2008 Jan; 32 Suppl 1():31-6. PubMed ID: 18405055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of vascular stiffness in vascular dementia, Alzheimer dementia and cognitive impairment.
    Rabkin SW; Jarvie G
    Blood Press; 2011 Oct; 20(5):274-83. PubMed ID: 21623679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.